127 related articles for article (PubMed ID: 9680262)
1. Lobeline and structurally simplified analogs exhibit differential agonist activity and sensitivity to antagonist blockade when compared to nicotine.
Terry AV; Williamson R; Gattu M; Beach JW; McCurdy CR; Sparks JA; Pauly JR
Neuropharmacology; 1998; 37(1):93-102. PubMed ID: 9680262
[TBL] [Abstract][Full Text] [Related]
2. Lobeline inhibits nicotine-evoked [(3)H]dopamine overflow from rat striatal slices and nicotine-evoked (86)Rb(+) efflux from thalamic synaptosomes.
Miller DK; Crooks PA; Dwoskin LP
Neuropharmacology; 2000 Oct; 39(13):2654-62. PubMed ID: 11044735
[TBL] [Abstract][Full Text] [Related]
3. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
Clarke PB; Reuben M
Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
[TBL] [Abstract][Full Text] [Related]
4. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors.
Rao TS; Correa LD; Lloyd GK
Neuropharmacology; 1997 Jan; 36(1):39-50. PubMed ID: 9144640
[TBL] [Abstract][Full Text] [Related]
5. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
Miller DK; Crooks PA; Zheng G; Grinevich VP; Norrholm SD; Dwoskin LP
J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762
[TBL] [Abstract][Full Text] [Related]
6. Lobeline and nicotine evoke [3H]overflow from rat striatal slices preloaded with [3H]dopamine: differential inhibition of synaptosomal and vesicular [3H]dopamine uptake.
Teng L; Crooks PA; Sonsalla PK; Dwoskin LP
J Pharmacol Exp Ther; 1997 Mar; 280(3):1432-44. PubMed ID: 9067333
[TBL] [Abstract][Full Text] [Related]
7. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.
Marks MJ; Farnham DA; Grady SR; Collins AC
J Pharmacol Exp Ther; 1993 Feb; 264(2):542-52. PubMed ID: 8437106
[TBL] [Abstract][Full Text] [Related]
8. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro.
el-Bizri H; Clarke PB
Br J Pharmacol; 1994 Feb; 111(2):406-13. PubMed ID: 8004384
[TBL] [Abstract][Full Text] [Related]
9. 86Rb+ efflux mediated by alpha4beta2*-nicotinic acetylcholine receptors with high and low-sensitivity to stimulation by acetylcholine display similar agonist-induced desensitization.
Marks MJ; Meinerz NM; Brown RW; Collins AC
Biochem Pharmacol; 2010 Oct; 80(8):1238-51. PubMed ID: 20599770
[TBL] [Abstract][Full Text] [Related]
10. Differential mechanisms involved in the effect of nicotinic agonists DMPP and lobeline to release [3H]5-HT from rat hippocampal slices.
Lendvai B; Sershen H; Lajtha A; Santha E; Baranyi M; Vizi ES
Neuropharmacology; 1996; 35(12):1769-77. PubMed ID: 9076756
[TBL] [Abstract][Full Text] [Related]
11. Methyllycaconitine is a potent antagonist of alpha-conotoxin-MII-sensitive presynaptic nicotinic acetylcholine receptors in rat striatum.
Mogg AJ; Whiteaker P; McIntosh JM; Marks M; Collins AC; Wonnacott S
J Pharmacol Exp Ther; 2002 Jul; 302(1):197-204. PubMed ID: 12065717
[TBL] [Abstract][Full Text] [Related]
12. Effects of stimulation or blockade of central nicotinic-cholinergic receptors on performance of a novel version of the rat stimulus discrimination task.
Terry AV; Buccafusco JJ; Jackson WJ; Zagrodnik S; Evans-Martin FF; Decker MW
Psychopharmacology (Berl); 1996 Jan; 123(2):172-81. PubMed ID: 8741940
[TBL] [Abstract][Full Text] [Related]
13. Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function.
Xiao Y; Meyer EL; Thompson JM; Surin A; Wroblewski J; Kellar KJ
Mol Pharmacol; 1998 Aug; 54(2):322-33. PubMed ID: 9687574
[TBL] [Abstract][Full Text] [Related]
14. Introduction of unsaturation into the N-n-alkyl chain of the nicotinic receptor antagonists, NONI and NDNI: effect on affinity and selectivity.
Sumithran SP; Crooks PA; Xu R; Zhu J; Deaciuc AG; Wilkins LH; Dwoskin LP
AAPS J; 2005 Aug; 7(1):E201-17. PubMed ID: 16146341
[TBL] [Abstract][Full Text] [Related]
15. Regulation of brain nicotinic receptors by chronic agonist infusion.
Bhat RV; Turner SL; Selvaag SR; Marks MJ; Collins AC
J Neurochem; 1991 Jun; 56(6):1932-9. PubMed ID: 2027007
[TBL] [Abstract][Full Text] [Related]
16. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum.
Clarke PB; Reuben M; el-Bizri H
Br J Pharmacol; 1994 Mar; 111(3):695-702. PubMed ID: 8019748
[TBL] [Abstract][Full Text] [Related]
17. Desensitization of nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes.
Marks MJ; Grady SR; Yang JM; Lippiello PM; Collins AC
J Neurochem; 1994 Dec; 63(6):2125-35. PubMed ID: 7964732
[TBL] [Abstract][Full Text] [Related]
18. Nicotinic agonists differ in activation and desensitization of 86Rb+ efflux from mouse thalamic synaptosomes.
Marks MJ; Robinson SF; Collins AC
J Pharmacol Exp Ther; 1996 Jun; 277(3):1383-96. PubMed ID: 8667201
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological activity of N-methyl-carbamylcholine, a novel acetylcholine receptor agonist with selectivity for nicotinic receptors.
Boksa P; Quik M; Mitchell JB; Collier B; O'Neil W; Quirion R
Eur J Pharmacol; 1989 Nov; 173(1):93-108. PubMed ID: 2606158
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes.
Lu Y; Grady S; Marks MJ; Picciotto M; Changeux JP; Collins AC
J Pharmacol Exp Ther; 1998 Nov; 287(2):648-57. PubMed ID: 9808692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
